IDRA - Idera Pharmaceuticals beats by $0.07 misses on revenue May, 02 2019 05:10 PM Idera Pharmaceuticals Inc. Idera Pharmaceuticals (NASDAQ:IDRA): Q1 GAAP EPS of -$0.40 beats by $0.07.More news on: Idera Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...